Previous Article | Next Article ![]()
Infection and Immunity, September 2000, p. 5198-5204, Vol. 68, No. 9
Division of Geographic Medicine, Case Western
Reserve University School of Medicine and University Hospitals of
Cleveland, Cleveland, Ohio1; Kenya
Medical Research Institute, Kisian,2 and
Division of Vector Borne Diseases, Ministry of Health,
Nairobi,3 Kenya; and Division of
Parasitic Diseases, National Center for Infectious Diseases,
Centers for Disease Control and Prevention, Atlanta,
Georgia4
Received 19 January 2000/Returned for modification 17 March
2000/Accepted 12 June 2000
Seasonal epidemics of malaria occur in highland areas of western
Kenya where transmission intensity varies according to rainfall. This
study describes the seasonal changes in cytokine responses to
Plasmodium falciparum liver-stage antigen 1 (LSA-1) by
children ( Epidemics of malaria in the
highlands of Uasin Gishu district of Kenya have been reported
intermittently since 1902 (1, 3, 8, 12, 17, 18). These
outbreaks usually occur during the rainy season (generally between
April and September), when the number of Anopheles
mosquitoes increases (17). Since the late 1980s, highland
malaria epidemics have occurred more frequently and caused significant
morbidity and mortality during the rainy season (37). The
partial immunity to malaria that develops in adults living in areas
where malaria is holoendemic is associated with repeated and frequent
exposure to infective mosquitoes (36). In highland areas,
prolonged periods of low or no exposure to infective mosquitoes during
the dry season presumably results in reduction in the number of
parasites that become established in the liver. This may in turn lead
to diminished antigen-specific immunity to pre-erythrocytic and
blood-stage Plasmodium falciparum with increased
susceptibility to malaria infection when transmission rises during the
rainy season.
To date, the only longitudinal study of immune responses in epidemic
highland malaria has been done in Madagascar and was concerned with a
blood-stage antigen. Examination of adult residents during an epidemic
in 1986 to 1987 showed that antibody levels and lymphocyte
proliferation to Pf155 ring-infected erythrocyte surface antigen
peptides decreased after the outbreak was controlled. Cytokine
responses were not reported (27). Studies on immune responses in areas of Sudan with unstable malaria transmission have focused primarily on antibody responses (4, 9, 10, 39).
Prospective studies of seasonal changes in malaria antigen-specific immune responses in areas where malaria is holoendemic have also focused primarily on antibody and lymphocyte proliferation responses (31, 32). The importance of cytokines in mediating
resistance against pre-erythrocytic malaria infection has been
documented in animal models (21, 34, 35, 38) and suggested
by observations of naturally infected and
irradiated-sporozoite-immunized humans (23, 25, 26). We
therefore examined antigen-specific cytokine responses of residents of
a village in the highlands of western Kenya during the rainy and dry seasons.
This study focused on P. falciparum liver-stage antigen 1 (LSA-1), an ~200-kDa molecule expressed exclusively during hepatic schizogony (11, 42). Previous studies of cytokine responses to LSA-1 have been conducted in residents of areas of Africa and Papua
New Guinea where malaria is holoendemic. These have documented gamma
interferon (IFN- Human subjects.
Volunteers were residents of the village of
Kabobo in Uasin Gishu district of Kenya. Kabobo is situated at an
elevation of approximately 7,000 feet (2,134 m). The nearest paved road
is located 10 miles from the village. P. falciparum
transmission is unstable, and epidemics of malaria with high morbidity
and mortality have been described (37). The regular
outbreaks of malaria that occur in this area every rainy season may be
indicative of a gradual change in malaria endemicity in this area from
epidemic to seasonally endemic. Only P. falciparum and
Plasmodium malariae species have been documented. The great
majority of malaria is due to P. falciparum (17).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cytokine Responses to Plasmodium falciparum
Liver-Stage Antigen 1 Vary in Rainy and Dry Seasons in Highland
Kenya
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
17 years old) and adults (
18 years old) living in
such a highland area. Fourteen- to 24-mer peptides
corresponding to the N- and C-terminal nonrepeat regions of LSA-1
stimulated production of interleukin-5 (IL-5), interleukin-10 (IL-10),
gamma interferon (IFN-
), and tumor necrosis factor alpha (TNF-
)
by peripheral blood mononuclear cells (PBMC) from 17 to 73% of
individuals in both age groups in both seasons. IL-10 and TNF-
responses were more frequent during the high-transmission, rainy
season than during the low-transmission, dry season (73 and 67% versus
17 and 25% response rates, respectively). In contrast, there was no
seasonal change in the proportion of LSA-1-driven IFN-
and IL-5
responses. Children produced less IFN-
than adults, but IL-5, IL-10,
and TNF-
levels were similar for both age groups. Depletion of
CD8+ cells from PBMC decreased IFN-
but increased IL-10
production. Individuals with LSA-1-stimulated IL-10 responses in
the dry season were less likely to become reinfected in the subsequent
rainy season than those without IL-10 responses (25% versus 49%;
P = 0.083). These data support the notion that
maintenance of LSA-1-driven IL-10 and TNF-
responses requires
repeated and sustained exposure to liver-stage P. falciparum. In contrast, IFN-
responses increase slowly with
age but persist once acquired. CD8+ T cells are the major
source of IFN-
but may suppress production or secretion of
IL-10.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), tumor necrosis factor alpha (TNF-
), interleukin-10 (IL-10), and cytotoxic T-lymphocyte (CTL) responses to
polypeptides encoded by the N- and C-terminal nonrepeat regions of LSA-1 (5, 7, 13, 23, 25, 26). Recent observations of
Gabonese children have shown a decreased rate of reinfection in
individuals whose peripheral blood mononuclear cells (PBMC) made
IFN-
in response to LSA-1 (25). In addition, examination of residents of an area of Kenya where malaria is holoendemic, located
approximately 50 miles from the current study site, showed that IL-10
responses to recombinant LSA-1 proteins correlated with a delayed rate
of reinfection following radical cure with chemotherapy
(23). These and other studies of CTL responses to LSA-1
(13) support its inclusion in a multistage malaria vaccine.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
18 years old, and children were
defined as persons
17 years old. The cytokine responses of 80 individuals (25 children, age range of 1 to 17 years; 55 adults, age
range of 18 to 80 years) were investigated during the rainy season in
August 1996. One hundred twelve individuals (36 children [age range, 2 to 17 years] and 76 adults [age range, 18 to 80 years]) were studied
during the dry season in March 1997. Thirty-seven subjects were tested
for IFN-
production at both time points. Twelve subjects were tested
for IL-10 production at both time points.
Seasonal changes in malaria prevalence. Thick and thin smears of fingerprick blood samples from 6- to 12-year-old schoolchildren were examined for P. falciparum in October 1996, at the end of the rainy season, and in March 1997, at the end of the dry season. One hundred eighty children were tested in October, and 201 children were tested in March.
Preparation of PBMC and cytokine assays.
Blood was
anticoagulated with heparin and transported from the field to the
laboratory within 4 h of venipuncture. PBMC were separated from
whole blood by Hypaque-Ficoll density gradient centrifugation. For
cytokine assays, 106 PBMC with or without peptide, antigen,
or mitogen were incubated for 5 days in culture medium, and
supernatants were stored at
70°C before transport to Cleveland.
IL-5, IL-10, IFN-
, and TNF-
were measured by two-site
enzyme-linked immunosorbent assay as previously described
(19). IFN-
production was measured prior to testing for
other cytokines. The limited amount of supernatant precluded testing
all samples for all cytokines from each time period. Cytokine
concentrations in supernatants of unstimulated (control) cultures were
subtracted from the values of peptide or antigen/mitogen-stimulated cultures.
, CD8+
cells were removed from PBMC with immunomagnetic beads as described elsewhere (20). The depleted cell population was then
stimulated with LSA-1 peptides as described above. Depletion with
immunomagnetic beads removed >98% of CD8+ cells as
detected by immunofluorescent staining with anti-CD8 antibody.
LSA-1 peptides, antigens, and mitogens.
Five peptides, one
from the N-terminal and four from the C-terminal nonrepeat regions of
LSA-1 (NF54 strain of P. falciparum, GenBank accession no.
X56203) were used. The amino acid sequences were residues 84 to 107 (LTMSNVKNVSQTNFKSLLRNLGVS), 1742 to 1760 (HTLETVNISDVNDFQISKY), 1813 to
1835 (NENLDDLDEGIEKSSEELSEEKI), 1836 to 1849 (KKGKKYEKTKDNNF), and 1888 to 1909 (DNEILQIVDELSEDITKYFMKL). Peptides were synthesized by 9-fluorenylmethoxy carbonyl
chemistry (15) (kindly supplied by Nga Nguyen, Food and Drug
Administration) and used at a concentration of 10 µg/ml with the
exception of peptide 1836-1849, which was used at 2 µg/ml. Peptides
84-107, 1813-1835, and 1888-1909 have been shown to stimulate
proliferation of PBMC from North Americans inoculated with irradiated
P. falciparum sporozoites (22) and IFN-
production by adults living in an area of Papua New Guinea where
malaria is holoendemic (5). Phytohemagglutinin (1 µg/ml)
was used as a mitogen control, and streptolysin O (10 µg/ml) and/or
Mycobacterium tuberculosis purified protein derivative (10 µg/ml) served as nonmitogen antigen controls. Only those PBMC
preparations that produced cytokines in response to these three
controls were included in the analysis.
Statistics.
Differences in the frequency of positive
cytokine responses to LSA-1 peptides were compared by the
2 test. Quantitative differences in the level of
cytokine production were evaluated by the nonparametric Mann-Whitney U
test. The correlation between the levels of two cytokines was assessed
by the Spearman rank test. Association of positive responses between
two cytokines was assessed by contingency table analysis
(
2 test). Quantitative differences in the level of
cytokine production for the paired PBMC and CD8+
cell-depleted PBMC samples were evaluated by the nonparametric Wilcoxon
matched-pairs signed-rank test.
2 test. Cytokine responders were
compared to nonresponders for time to appearance of parasitemia, the
percentage of individuals who had a positive blood smear for P. falciparum within the 10 weeks of chemotherapy-induced cure, and
the mean level of parasitemia. Time to appearance of parasitemia was
assessed by Kaplan-Meier survival analysis (with differences compared
by the log-rank test) and Cox proportional hazards. The percentage of
blood smear-positive individuals in each group was compared using
two-way contingency table (
2) analysis. The mean levels
of asexual parasitemia were compared by Student's t test.
| |
RESULTS |
|---|
|
|
|---|
Prevalence of blood-stage P. falciparum infection during the rainy and dry seasons. In October 1996, near the end of the rainy season, 82 of 180 schoolchildren (45.5%) had P. falciparum parasitemia. In March 1997, at the end of the dry season, only 18 of 201 schoolchildren (8.9%) were parasitemic (P < 0.001). No other Plasmodium species were observed. Among the study subjects, 47 of 80 (58.7%) and 18 of 112 (16.1%) individuals were parasitemic in the rainy and dry seasons, respectively (P < 0.001).
Cytokine responses by North Americans.
PBMC from North
Americans were examined because some malaria antigens have been found
to stimulate lymphocyte responses by persons who have never been
infected or exposed to the parasite (41). Cytokine
production of >20 pg/ml in response to one or more LSA-1 peptides was
observed for PBMC from 3 of 14 individuals for IL-5, 5 of 13 for IL-10,
5 of 14 for IFN-
, and 6 of 14 for TNF-
. The cutoff value for a
positive response by Kenyan study subjects was defined as greater than
the mean plus 2 standard deviations (SD) of the North American
controls. Positive responses were defined as follows: for IL-5, >72
pg/ml; for IL-10, >132 pg/ml; for IFN-
, >214 pg/ml; and for
TNF-
, >188 pg/ml.
Frequency of PBMC cytokine responses to various LSA-1 peptides by
residents of the Kenyan highlands.
IL-5, IL-10, IFN-
, and
TNF-
were produced in response to one or more LSA-1 peptides (Table
1). IL-10 responses to the N-terminal 84-107 peptide were less frequent than to any of the C-terminal peptides (P < 0.01). Similarly, a lower frequency of
TNF-
responses to the N-terminal 84-107 than the C-terminal
1836-1849 peptide was observed (P = 0.01). The
frequencies of responses to the other C-terminal peptides were similar
to that of the N-terminal peptide. No significant differences between
the rates of responses to the N-terminal and C-terminal peptides were
noted for IFN-
or IL-5.
|
responses were more common during the rainy than dry
season (PBMC from 73.2 and 66.7% of subjects made each cytokine to at
least one peptide during the rainy season, compared with 17.0 and
24.6% during the dry season; P < 0.001). The
decreased IL-10 and TNF-
response rates during the dry season were
most striking for the C-terminal 1813-1835, 1836-1849, and 1888-1909 peptides (Table 1). The frequencies of IL-5 and IFN-
responses were
similar during both seasons (P > 0.10).
Thirty-seven individuals (age range, 6 to 54 years) donated blood in
both rainy and dry seasons. There was a sufficient amount of
supernatants from PBMC at both time points to measure only two
cytokines. We first measured IFN-
since earlier studies of pre-erythrocytic immunity have focused on this mediator (5, 7,
25). In the rainy season, 20 individuals had PBMC that produced
IFN-
when stimulated with one or more LSA-1 peptides. Fourteen of
twenty subjects (70%) who responded at this time continued to do so
during the dry season. Of the 17 individuals whose PBMC did not produce
IFN-
in the rainy season, 8 (47%) had responses during the dry
season. The levels of IFN-
for these individuals were similar across
seasons (median IFN-
level in rainy season = 240 pg/ml; median
in dry season = 286 pg/ml; P > 0.05). Enough supernatant remained to measure IL-10 levels in both seasons for 12 of
37 individuals. Nine of the twelve individuals had a decrease in IL-10
level in response to LSA-1, and the median IL-10 level in response to
LSA-1 in these individuals decreased from 289 to 64 pg/ml (P = 0.049).
The frequency of cytokine responses was similar when the study subjects
were grouped according to the presence or absence of blood-stage
P. falciparum on thick smear, use of antimalarial medication
within the previous 2 weeks, or clinical symptoms and signs of malaria
(data not shown).
Relationship of age to cytokine responses.
Table
2 describes the frequencies and levels of
cytokine responses for persons
17 and those
18 years old. A pattern
similar to that of the entire population was observed; i.e., for both children and adults, the frequencies and median levels of IL-10 and
TNF-
responses were greater in the rainy than dry season, whereas
IL-5 and IFN-
responses did not change. For example, the median
levels of IL-10 produced by children during the rainy and dry seasons
were, respectively, 201 and 37 pg/ml (P < 0.001). The
frequencies and levels of cytokine responses were similar in children
and adults for all cytokines except IFN-
, for which the frequency of
responses was lower in children than adults (e.g., during the dry
season, 31% of children responded, compared with 53% of adults;
P = 0.028).
|
Cytokine production and resistance to reinfection with
P. falciparum.
Kaplan-Meier survival analysis
demonstrated a trend toward prolonged time to reinfection for IL-10
responders to LSA-1 compared with nonresponders (Fig.
1). The difference did not reach
statistical significance at the 10-week follow-up (P = 0.15). A lower percentage of IL-10 responders than nonresponders
also developed blood-stage infection detectable by inspection of thick
smears (25.0% versus 49.2%). This difference approached statistical
significance (P = 0.083) (Table
3). There was no difference in the period
of time to development of P. falciparum parasitemia when
subjects were grouped according to whether or not their PBMC produced
IL-5, IFN-
, or TNF-
in response to LSA-1 peptides (data not
shown). The percentages of IL-5, IFN-
, and TNF-
responders and
nonresponders who developed parasitemia in the 10-week follow-up period
also did not differ significantly (Table 3). There was no difference in
the level of parasitemia between responders and nonresponders for any
cytokine tested (data not shown).
|
|
Correlation between production of various cytokines.
LSA-1-stimulated PBMC production of all four cytokines was measured in
56 subjects during the dry season. (This correlation was not examined
during the rainy season since PBMC from only 18 subjects studied at
this time had a sufficient amount of culture supernatant to measure all
four cytokines.) A positive correlation was observed between all pairs
of cytokines evaluated except TNF-
and IFN-
(Table
4).
|
Contribution of CD8+ cells to LSA-1-stimulated IFN-
and IL-10 production.
The effect of CD8+ cell
depletion on LSA-1 peptide-stimulated IFN-
production was studied in
six individuals whose PBMC produced this cytokine in response to one or
more LSA-1 peptides. The level of IFN-
decreased by 85% following
depletion of CD8+ cells (median level for nonfractionated
PBMC = 266 pg/ml [range, 224 to 2,184 pg/ml] versus 40 pg/ml
[range, 1 to 944 pg/ml] for CD8+ cell-depleted PBMC;
P = 0.028) (Fig. 2). The
effect of CD8+ cell depletion on IL-10 production was
studied in 11 individuals. IL-10 production increased following
depletion of CD8 cells from PBMC of nine subjects (Fig.
3). The median level of IL-10 for the
depleted population was 66 pg/ml (range, 25 to 170 pg/ml) versus 15 pg/ml (range, 1 to 70 pg/ml) for nonfractionated PBMC (P = 0.007).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Malaria epidemics in the highlands of Kenya are characterized by
abrupt and transient increases in infection and morbidity that coincide
with periods of heightened transmission following prolonged dry spells.
The epidemiology of highland malaria differs from that in areas where
malaria is holoendemic in that adults as well as children appear to be
affected (3, 8, 37). This study describes the temporal
changes in antigen-specific T-cell cytokine responses that are believed
to contribute to elimination of liver-stage malaria. LSA-1-driven IL-10
and TNF-
responses, unlike IFN-
and IL-5 responses, were observed
to be weaker in the dry, low-transmission season than in the rainy,
high-transmission season. The data suggest that lack of frequent and
repeated exposure to liver-stage P. falciparum during the
dry season leads to decreased immunologic boosting and waning of
LSA-1-specific IL-10 and TNF-
responses. It is not yet clear why
antigen-specific T-cell IFN-
and IL-5 responses are not affected in
the same way. The results also suggest a trend toward an association
between protection from P. falciparum reinfection and
LSA-1-driven IL-10 but not TNF-
, IFN-
, or IL-5 responses.
Although these data were obtained from repeated cross-sectional studies
of different groups of individuals living in the same area where
malaria is endemic, the patterns were similar for IFN-
and IL-10
responses of a subset of the same persons evaluated in both seasons.
Data comparing the frequency and magnitude of cytokine responses by
children and adults suggest that acquisition of T-cell IFN-
responses to LSA-1, unlike the other cytokines examined, was related to
cumulative and long-term exposure to infection. Once acquired, IFN-
responses appear to persist.
Two recent studies have highlighted an association between LSA-1-driven
IL-10 responses and P. falciparum infection and morbidity. Luty et al. (26) performed a case-control study of Gabonese children with mild and severe malaria. Parasite clearance times in
children with mild malaria were more rapid in those with PBMC IL-10
responses to LSA-1 peptides than in those without IL-10 responses.
IL-10 production correlated with higher-level acute-phase antibody
responses, which were also associated with rapid parasite clearance.
Kurtis et al. (23) demonstrated that IL-10 production in
response to recombinant LSA-1 proteins correlated with resistance to
reinfection in adults living in an area of western Kenya where malaria
is holoendemic. These observations, together with the present data
showing that LSA-1-driven IL-10 production diminishes during the dry
season, suggest that IL-10 mediates or indirectly contributes to
elimination of liver-stage P. falciparum. Ho et al. have
suggested that IL-10 down-regulates proinflammatory cytokines such as
IFN-
and TNF-
in acute malaria (14), and the former cytokine has been shown to decrease antigen-specific T-cell cytokine production in general (6). Our observations do not support the notion that IL-10 suppresses LSA-1-driven IFN-
, TNF-
, or IL-5
since a negative correlation between IL-10 and the latter cytokines was
not observed. Rather, the present findings are similar to those of
Wenisch et al., who reported a positive correlation between serum IL-10
and IFN-
in acute P. falciparum infection (40). More detailed examination of the regulatory role of
IL-10 in pre-erythrocytic immunity requires measurement of production of various cytokines in the presence of neutralizing anti-IL-10 antibodies and a better understanding of whether IL-10 influences accumulation and activation of local effector cells, such as
CD8+ CTL and CD8+ IFN-
-secreting cells in
the liver.
The role of TNF-
in malaria is complex and incompletely understood.
Increased serum TNF-
levels have been reported in severe malaria
(e.g., cerebral malaria) and uncomplicated morbidity (fever with
parasitemia) (24, 28). The relationship between malaria antigen-specific T-cell TNF-
responses and liver-stage infection is
less well studied. In the present study, the magnitude of the reduction
in LSA-1-induced TNF-
from rainy to dry season was almost as marked
as the decrease in IL-10 responses. The relatively more robust
LSA-1-driven TNF-
response during the rainy season was not
attributable to severe malaria since none of the study subjects had
symptoms consistent with this illness. In addition, infection status
documented by blood smear did not correlate with TNF-
responses, and
unlike the case for LSA-1-induced IL-10 responses, there was no trend
toward protection from infection with LSA-1-induced TNF-
responses.
The lower number of individuals tested for TNF-
production
(n = 54) than for IL-10 (n = 77) may
have made correlation between protection and TNF-
responses more
difficult to detect. Others have reported a lack of correlation between
LSA-1-induced TNF-
and protection against infection (23,
25). It is possible that LSA-1-driven TNF-
responses correlate
with relative resistance against severe morbidity rather than
infection, although at present morbidity is thought to be associated
primarily with immunity to blood-stage antigens.
IFN-
is an important mediator of resistance to liver-stage malaria
and the pathogenesis of disease in animal models (29, 30,
35), and LSA-1-specific T-cell IFN-
responses develop in North
American volunteers in whom sterile, transient immunity to P. falciparum infection has been induced by immunization with radiation-attenuated sporozoites (22). We observed no
seasonal changes in the strength of LSA-1-induced IFN-
responses in
the highland study subjects and no correlation between LSA-1-induced IFN-
responses and resistance to reinfection with P. falciparum. In a study conducted in a nearby area where malaria is
holoendemic, the findings of Kurtis et al. were very similar: the
proportion of persons who made IFN-
in response to recombinant LSA-1
protein decreased at the end of the dry season, but there was no
association between these responses and the time to reinfection
(23). In contrast, Luty et al. observed that LSA-1-driven
IFN-
production was associated with delayed infection and reduction
in the rate of reinfection in children (25). A previous
study of adults in Papua New Guinea demonstrated that IFN-
responses
to the N-terminal 84-107 peptide were associated with repeatedly
negative smears for P. falciparum over a 6-month period
(5). Since we were able to document a trend toward
protection from infection in individuals with IL-10 responses to LSA-1,
and since our study numbers were even larger for IFN-
(n = 94), the very similar rates of infection in those with and
without IFN-
responses to LSA-1 suggest that, at least in this
population, LSA-1-induced IFN-
production is not strongly protective
against infection. As with TNF-
responses, it is possible that
LSA-1-induced IFN-
responses relate more to malarial morbidity than
to infection.
The most remarkable age-associated difference observed in the present
study was related to IFN-
, the only cytokine for which there were
fewer responses by children than by adults. One explanation is that
multiple exposures and greater cumulative experience with liver-stage
P. falciparum are required to induce IFN-
but not IL-5,
IL-10, or TNF-
responses to LSA-1. If this is so, the present findings suggest that once a given threshold is reached, LSA-1-induced IFN-
responses persist even when transmission intensity decreases. In this context, it will be of interest to determine the phenotypes of
the T-cell subsets that produce IFN-
(see below), whether they have
markers of the memory phenotype (e.g., CD45RO) (2), and
whether they differ from those of T cells that secrete other cytokines
when stimulated with LSA-1.
Because of limitations in the number of PBMC available from the study
subjects, we were not able to perform detailed experiments to determine
the subsets of T cells that made each of the cytokines. Based on the
length of the peptides used to stimulate cytokine production (14 to 24 amino acids), both CD4+ and CD8+ T cells
restricted by HLA class I and II molecules may have contributed. Results of experiments in which CD8+ cells were depleted by
immunomagnetic selection suggested that this subset is the major but
not only source of IFN-
. CD8+ T cells were also the
predominant source of IFN-
following stimulation with the LSA-1
84-107 peptide in studies conducted in Papua New Guinea (K. Bucci,
unpublished data). By contrast, LSA-1-driven IL-10 production was
enhanced following depletion of CD8+ cells (in 9 of 11 individuals). It is not clear whether this modest increase in cytokine
production was due to removal of cells that secrete molecules which
actively suppress production of IL-10 by the remaining monocytes and
CD4+ T cells or removal of a source for consumption of
IL-10. Since IL-10 is a chemoattractant for CD8+
(16), it is possible that this cytokine is involved in
elimination of liver-stage parasites by virtue of its effects on the
local accumulation of effector cells, such as IFN-
-secreting CD8 cells.
Our study establishes that select LSA-1-driven cytokine responses in highland residents vary according to season and supports the idea that LSA-1-induced IL-10 production may have a role in protection from P. falciparum infection. Future studies will focus on determining whether seasonal changes in CD4+ and CD8+ T-cell immunity to LSA-1 (and other pre-erythrocytic or blood-stage malaria antigens) (29, 30, 33) are predictive of the rate and clonality of reinfection, high-density parasitemia, and uncomplicated malaria morbidity in children and adults.
| |
ACKNOWLEDGMENTS |
|---|
This work was published with the kind permission of Davy Koech, Director of the Kenya Medical Research Institute. We thank Venkatachalam Udhayakumar for his guidance and for the use of CDC laboratory space in Kisian, Evan Secor for suggestions and critiques, David Koech and Johanna Milgo for inspection of blood smears, and Elkanah Gichana Ondere for assistance in the laboratory. We also thank the volunteers for their participation in this study.
This work was supported by NIH grants AI-01572 and AI-43906.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Geographic Medicine, Case Western Reserve University School of Medicine, W137, 2109 Adelbert Road, Cleveland, OH 44106-4983. Phone: (216) 844-3645. Fax: (216) 368-4825. E-mail: ccj{at}po.cwru.edu.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, T. 1929. Investigations for the health conditions in the Trans Nzoia with special reference to malaria. East Afr. Med. J. 6:274. |
| 2. | Bergmann, E. S., R. W. Ballou, and U. Krzych. 1997. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Cell Immunol. 180:143-152[CrossRef][Medline]. |
| 3. | Campbell, J. 1929. Malaria in Uasin Gishu and Trans Nzoia. East Afr. Med. J. 6:32. |
| 4. |
Cavanagh, D. R.,
I. M. Elhassan,
C. Roper,
V. J. Robinson,
H. Giha,
A. A. Holder,
L. Hviid,
T. G. Theander,
D. E. Arnot, and J. S. McBride.
1998.
A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.
J. Immunol.
161:347-359 |
| 5. | Connelly, M., C. L. King, K. Bucci, S. Walters, B. Genton, M. P. Alpers, M. Hollingdale, and J. W. Kazura. 1997. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect. Immun. 65:5082-5087[Abstract]. |
| 6. | Del Prete, G., M. de Carli, F. Almerigogna, M. Guidini, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353-360[Abstract]. |
| 7. | Fidock, D., H. Gras-Masse, J. Lepers, K. Brahimi, L. Benmohamed, S. Mellouk, C. Guerin-Marchand, A. Londono, L. Raharimalala, J. Meis, et al. 1994. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 153:190-204[Abstract]. (Erratum, 153:5347.) |
| 8. | Garnham, P. 1945. Malaria epidemic at exceptionally high altitude in Kenya. Br. Med. J. 14:45. |
| 9. |
Giha, H. A.,
T. Staalsoe,
D. Dodoo,
I. M. Elhassan,
C. Roper,
G. M. Satti,
D. E. Arnot,
T. G. Theander, and L. Hviid.
1999.
Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes.
Infect. Immun.
67:4092-4098 |
| 10. | Giha, H. A., T. Staalsoe, D. Dodoo, C. Roper, G. M. Satti, D. E. Arnot, L. Hviid, and T. G. Theander. 2000. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol. Lett. 71:117-126[CrossRef][Medline]. |
| 11. | Guerin-Marchand, C., P. Druilhe, B. Galey, A. Londono, J. Patarapotikul, R. Beaudoin, C. Dubeaux, A. Tartar, O. Mercereau-Puijalon, and G. Langsley. 1987. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329:164-167[CrossRef][Medline]. |
| 12. | Heisch, R. 1945. Epidemic of malaria in the Kenya highlands transmitted by A. funestus. J. Trop. Med. Hyg. 52:187. |
| 13. | Hill, A., J. Elvin, A. Willis, M. Aidoo, C. Allsopp, F. Gotch, X. Gao, M. Takiguchi, B. Greenwood, A. Townsend, et al. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439[CrossRef][Medline]. |
| 14. | Ho, M., M. Sexton, P. Tongtawe, S. Looareesuwan, P. Suntharasamai, and H. Webster. 1995. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172:838-844[Medline]. |
| 15. |
Houghten, R. A.
1985.
General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interactions at the level of individual amino acids.
Proc. Natl. Acad. Sci. USA
82:5131-5136 |
| 16. | Jinquan, T., C. Larsen, B. Gesser, K. Matsushima, and K. Thestrup-Perdersen. 1993. Human IL-10 is a chemoattractant for CD8+ lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J. Immunol. 151:4545-4551[Abstract]. |
| 17. | Khaemba, B., A. Mutani, and M. Bett. 1994. Studies of anopheline mosquitoes transmitting malaria in a newly developed highland urban area: a case study of Moi University and its environs. East Afr. Med. J. 71:159-164[Medline]. |
| 18. | Khan, B., V. Ofulla, D. Kariuki, J. Githure, E. Kabiru, and S. Martin. 1992. Drug sensitivity studies during a highland malaria epidemic in Kenya. Trans. R. Soc. Trop. Med. Hyg. 86:371-372[CrossRef][Medline]. |
| 19. | King, C., A. Medhat, I. Malhotra, M. Nafeh, A. Helmy, J. Khaudary, S. Ibrahim, M. El-Sherbiny, S. Zaky, R. Stupi, K. Brustoski, M. Shehata, and M. Shata. 1996. Cytokine control of parasite-specific anergy in human urinary schistosomiasis: IL-10 modulates lymphocyte reactivity. J. Immunol. 156:4715-4721[Abstract]. |
| 20. | King, C., R. Stupi, N. Craighead, C. June, and G. Thyphoronitis. 1995. CD28 promotes Th2 differentiation by human CD4+ cells. Eur. J. Immunol. 25:587-595[Medline]. |
| 21. | Kobayashi, F., T. Morii, T. Matsui, T. Fujino, Y. Watanabe, W. Weidanz, and M. Tsuji. 1996. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii. Parasitol. Res. 82:385-391[CrossRef][Medline]. |
| 22. | Krzych, U., J. Lyon, T. Jareed, I. Schneider, M. Hollingdale, D. Gordon, and W. Ballou. 1995. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155:4072-4077[Abstract]. |
| 23. |
Kurtis, J.,
D. Lanar,
M. Opollo, and P. Duffy.
1999.
Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.
Infect. Immun.
67:3424-3429 |
| 24. | Kurtzhals, J. A., V. Adabayeri, B. Q. Goka, B. D. Akanmori, J. O. Oliver-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1998. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772[CrossRef][Medline]. (Erratum, 352:242.) |
| 25. | Luty, A. J., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, F. Migot-Nabias, P. Deloron, R. S. Nussenzweig, and P. G. Kremsner. 1999. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J. Infect. Dis. 179:980-988[CrossRef][Medline]. |
| 26. | Luty, A. J., B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, S. Ulbert, F. Migot-Nabias, B. Dubois, P. Deloron, and P. G. Kremsner. 1998. Parasite antigen-specific interleukin-10 and antibody responses predict accelerated parasite clearance in Plasmodium falciparum malaria. Eur. Cytokine Netw. 9:639-646[Medline]. |
| 27. | Migot, F., C. Chougnet, L. Raharimalala, P. Astagneau, J. Lepers, and P. Deloron. 1993. Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar. Am. J. Trop. Med. Hyg. 48:432-439. |
| 28. | Mordmuller, B. G., W. G. Metzger, P. Juillard, B. M. Brinkman, C. L. Verweij, G. E. Grau, and P. G. Kremsner. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur. Cytokine Netw. 8:29-35[Medline]. |
| 29. | Nardin, E., and R. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:687-727[Medline]. |
| 30. | Plebanski, M., M. Aidoo, H. C. Whittle, and A. V. Hill. 1997. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 158:2849-2855[Abstract]. |
| 31. | Riley, E., S. Morris-Jones, M. Blackman, B. Greenwood, and A. Holder. 1993. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. Parasite Immunol. 15:513-524[Medline]. |
| 32. |
Scarselli, E.,
R. Tolle,
O. Koita,
M. Diallo,
H. Muller,
K. Fruh,
O. Doumbo,
A. Crisanti, and H. Bujard.
1993.
Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum.
Infect. Immun.
61:3490-3495 |
| 33. | Sedegah, M., B. Sim, C. Mason, T. Nutman, A. Malik, C. Roberts, A. Johnson, J. Ochola, D. Koech, B. Were, et al. 1992. Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol. 149:966-971[Abstract]. |
| 34. | Shear, H., C. Ng, and Y. Zhao. 1990. Cytokine production in lethal and non-lethal murine malaria. Immunol. Lett. 25:123-127[CrossRef][Medline]. |
| 35. | Shear, H., R. Srinivasan, T. Nolan, and C. Ng. 1989. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts. J. Immunol. 143:2038-2044[Abstract]. |
| 36. | Snow, R., J. Omumbo, B. Lowe, C. Molyneux, J. Obiero, A. Palmer, M. Weber, M. Pinder, B. Nahlen, C. Obonyo, C. Newbold, S. Gupta, and K. Marsh. 1997. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349:1650-1654[CrossRef][Medline]. |
| 37. | Some, E. 1994. Effects and control of highland malaria epidemic in Uasin Gishu District, Kenya. East Afr. Med. J. 71:2-8[Medline]. |
| 38. | Stevenson, M., M. Tam, and M. Nowotarski. 1990. Role of interferon-gamma and tumor necrosis factor in host resistance to Plasmodium chabaudi AS. Immunol. Lett. 25:115-121[CrossRef][Medline]. |
| 39. |
Vande Waa, J. A.,
J. B. Jensen,
M. A. Akood, and R. Bayoumi.
1984.
Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan.
Infect. Immun.
45:505-510 |
| 40. | Wenisch, C., B. Parschalk, E. Narzt, S. Looareesuwan, and W. Graninger. 1995. Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 74:115-117[CrossRef][Medline]. |
| 41. | Zevering, Y., F. Amante, A. Smillic, J. Currier, G. Smith, R. Houghten, and M. Good. 1992. High frequency of malaria specific T cells in non-exposed humans. Eur. J. Immunol. 22:689-696[Medline]. |
| 42. | Zhu, J., and M. Hollingdale. 1991. Structure of Plasmodium falciparum liver stage antigen-1. Mol. Biochem. Parasitol. 48:223-226[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»